Trial intelligence / Profile preview

Victoza in older prediabetic adults

NCT01784965Phase 3Completed

Sponsor
Stanford University
Start
Dec 2009
Primary completion
Dec 2012
Modality
Peptides
01

Overview

A Phase 3 trial of liraglutide in prediabetes, obesity, sponsored by Stanford University. Started Dec 2009; status: completed.

02

Drugs

03

Conditions

prediabetesobesity

Beyond the preview

Go deeper on NCT01784965.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01784965.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call